100 related articles for article (PubMed ID: 5748419)
21. [Polyacrylamide solution as a base for eyedrops with a lowered drug concentration].
Nuritdinov VA
Vestn Oftalmol; 1981; (2):50-1. PubMed ID: 7233687
[No Abstract] [Full Text] [Related]
22. [Polyacrylamide as a base for ophthalmic drug films].
Nuritdinov VA
Vestn Oftalmol; 1980; (5):59-60. PubMed ID: 7423735
[No Abstract] [Full Text] [Related]
23. [Sterilization and sterile preparations in pharmacy. 8. Water as a vehicle for sterile drugs].
Burelová A; Chalabala M
Cesk Farm; 1970 Oct; 19(8):312-8. PubMed ID: 5492517
[No Abstract] [Full Text] [Related]
24. [In situ gelling polymers for ophthalmic drops].
Sklubalová Z
Ceska Slov Farm; 2005 Jan; 54(1):4-10. PubMed ID: 15751788
[TBL] [Abstract][Full Text] [Related]
25. [Use of dimethyldodecylbenzylammonium chloride as a preservative for eyedrops].
Kondrat'eva TS; Mokhova GI; Samsonova MN
Farmatsiia; 1971; 20(1):26-9. PubMed ID: 5581135
[No Abstract] [Full Text] [Related]
26. The preservation of ophthalmic solutions with antibacterial combinations.
Richards RM; McBride RJ
J Pharm Pharmacol; 1971 Dec; 23():234S-235S. PubMed ID: 4401489
[No Abstract] [Full Text] [Related]
27. Eyelid dermatitis due to sodium metabisulfite.
Seitz CS; Bröcker EB; Trautmann A
Contact Dermatitis; 2006 Oct; 55(4):249-50. PubMed ID: 16958926
[No Abstract] [Full Text] [Related]
28. [Sterilization and stability of idoxuridine containing ophthalmic solutions].
Backer ET; van de Langerijt JJ
Pharm Weekbl; 1966 Jun; 101(22):489-96. PubMed ID: 5940164
[No Abstract] [Full Text] [Related]
29. [Effectiveness, tolerance and acceptance of polyvidon preparations].
Höh H; Fink R; Dehnicke C; Klöcker N
Klin Monbl Augenheilkd; 1999 Oct; 215(4):A8-14. PubMed ID: 10572880
[No Abstract] [Full Text] [Related]
30. [Sterilization of ophthalmic products with gamma rays].
Giannetto A; Mazzone MG
Boll Chim Farm; 1992 Feb; 131(2):79-85. PubMed ID: 1503709
[No Abstract] [Full Text] [Related]
31. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
Bozdağ S; Gümüş K; Gümüş O; Unlü N
Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
[TBL] [Abstract][Full Text] [Related]
32. [Antimicrobial safety of eye drops and their adjustment].
Háze K; Dolezalová V
Cesk Farm; 1981 Nov; 30(9):319-21. PubMed ID: 7317956
[No Abstract] [Full Text] [Related]
33. An outline for preparing ophthalmic solutions.
Cadwallader DE
Am J Hosp Pharm; 1967 Jan; 24(1):32-6. PubMed ID: 6016342
[No Abstract] [Full Text] [Related]
34. [Contribution to the stability of papaverine. Part 6: The stability of aqueous solutions of papaverine hydrochloride (author's transl)].
Gundermann P; Pohloudek-Fabini R
Pharmazie; 1980 Dec; 35(12):764-6. PubMed ID: 7208577
[TBL] [Abstract][Full Text] [Related]
35. Cocaine hydrochloride topical solution prepared for ophthalmic use.
Fiscella RG; Lam J; Schell J; Siegel FP
Am J Hosp Pharm; 1993 Aug; 50(8):1572-4. PubMed ID: 8368210
[No Abstract] [Full Text] [Related]
36. Ophthalmic medications and pharmacology.
Duvall B; Kershner RM
J Ophthalmic Nurs Technol; 1998; 17(4):151-8. PubMed ID: 9883136
[No Abstract] [Full Text] [Related]
37. [Modern concepts of preparation of ophthalmic solutions].
Bagnarelli AE
Rev Sanid Milit Argent; 1967; 66(2):205-10. PubMed ID: 5613557
[No Abstract] [Full Text] [Related]
38. The preparation and sterilization of ophthalmic solutions.
HOGAN MJ
Calif Med; 1949 Dec; 71(6):414-6. PubMed ID: 15408108
[TBL] [Abstract][Full Text] [Related]
39. The effects of pH on contact lens wearing.
J Am Optom Assoc; 1969 Jul; 40(7):719-22. PubMed ID: 5824546
[No Abstract] [Full Text] [Related]
40. Quantitative cytotoxicity of preservatives evaluated in cell culture with Chang's human conjunctival cells--effect of temperature on cytotoxicity.
Takahashi N
Jpn J Ophthalmol; 1982; 26(2):234-8. PubMed ID: 7131932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
